Achievements
- Co-founded Reticular, a Y Combinator F24 startup transforming drug discovery with interpretable AI
- Graduated MIT in 2024 with a degree in Computer Science and Engineering
- Developed expertise in drug discovery, protein design, geometric deep learning, and NLP
- Co-authored papers with leading AI and biotech researchers like Jason Yim, Tommi Jaakkola, Regina Barzilay
- Built a vision to give pharma companies control over transparent, reliable AI protein models
- Formed a strong biotech and AI partnership with his MIT roommate since Olympiad days
The truth about John Yang
Lowkey, you gotta hear about John Yang – this guy’s the real deal in biotech and AI. So, he’s a co-founder of Reticular, a YC batch F24 startup that’s basically changing how we do drug discovery with interpretable AI. Think about that – AI that actually makes sense, not some black box bullshit. That’s his jam.
But here’s where it gets dope – John met his co-founder, Nithin Parsan, way back in the day at some great biology and neuroscience Olympiads. They crushed it together, and then they ended up rooming at MIT for four years. No cap, that’s like a dream team forming right there. They’ve been tight, passionate about tech and biology, and they’ve jumped into this crazy world of biotech innovation together.
John’s got a solid degree in Computer Science and Engineering from MIT, graduating in 2024. He’s not just some random tech guy – he’s deep into drug discovery, protein design, geometric deep learning, and natural language processing. Basically, he’s blending AI with biology at a level most people don’t even understand yet. And he’s co-authored papers with big brains like Jason Yim, Tommi Jaakkola, and Regina Barzilay – these are heavy hitters in AI and biotech.
Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.
Talk to herWhat’s super interesting is his mission with Reticular. He’s all about giving pharma companies real control over AI models for proteins – making them interpretable and reliable. That’s a huge deal because, right now, a lot of AI in pharma is kinda a black box. John and his team are pushing for transparency, trust, and real understanding in drug discovery, which could totally shake up the industry.
He’s based in SF now, obviously in the heart of the startup world, and he’s actively hunting for collaborations – with other startups, pharma teams, researchers into AI interpretability, all that. The guy’s really about having an effect, not just building cool tech for the sake of it.
Bottom line? John Yang is this rare combo of hardcore scientist, tech innovator, and startup founder who’s not just riding the AI wave but trying to make it honest and effective for medicine. Dude’s got the skills, the network, and the drive to change the game. No Cap, he’s one to watch.

Select your comment type:
If something is wrong about John Yang, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)